Format

Send to

Choose Destination
J Gen Intern Med. 2008 Jan;23 Suppl 1:64-8. doi: 10.1007/s11606-007-0300-7.

Trial registration for public trust: making the case for medical devices.

Author information

1
Division of General Internal Medicine, Department of Medicine, University of California, San Francisco, 400 Parnassus Ave., Rm. A-405, San Francisco, CA 94143-0320, USA. ida.sim@ucsf.edu

Abstract

Recently, several pharmaceutical companies have been shown to have withheld negative clinical trial results from the public. These incidents have resulted in a concerted global effort to register all trials at inception, so that all subsequent results can be tracked regardless of whether they are positive or negative. These trial registration policies have been driven in large part by concern about the pharmaceutical sector. The medical device industry is much smaller, and different from the pharmaceutical industry in some fundamental ways. This paper examines the issues surrounding registration of device trials and argues that these differences with pharmaceutical should not exempt device trials from registration.

PMID:
18095047
PMCID:
PMC2150638
DOI:
10.1007/s11606-007-0300-7
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center